Geron Announcement Throws Stem Cell Research into Question

In the wake of a California-based research company's decision to drop the world's first clinical trial using human embryonic stem cells, many investigators who once held to the promise of stem cell research now wonder whether the field of embryonic stem cell research has been abandoned in the U.S. completely. The company, Geron, which pioneered the field of embryonic stem cell research, announced its decision Monday to drop its study on stem cells for spinal cord injury. Geron cited costs as...Full Story